This Article Figures Only Full Text Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Sharma, S. Articles by McKenna, W. J. Search for Related Content PubMed PubMed Citation Articles by Sharma, S. Articles by McKenna, W. J.

CLINICAL STUDY

Utility of metabolic exercise testing in distinguishing hypertrophic cardiomyopathy from physiologic left ventricular hypertrophy in athletes

^a St. George’s Hospital Medical School, London, United Kingdom
^* University of Wolverhampton, Walsall Campus, Walsall, United Kingdom

Manuscript received July 29, 1999; revised manuscript received February 22, 2000, accepted April 11, 2000.

Reprint requests and correspondence: Dr. Sanjay Sharma, Department of Cardiological Sciences, St. George’s Hospital Medical School, Cranmer Terrace, London SW17 ORE, United Kingdom
ssharma21{at}hotmail.com

OBJECTIVES

This study evaluated the role of metabolic (cardiopulmonary gas exchange) exercise testing in differentiating physiologic LVH in athletes from HCM.

BACKGROUND

Regular intensive training may cause mild increases in left ventricular wall thickness (LVWT). Although the degree of left ventricular hypertrophy (LVH) is typically less than that seen in hypertrophic cardiomyopathy (HCM), genetic studies have shown that a substantial minority of patients with HCM have an LVWT in the same range. The differentiation of physiologic and pathologic LVH in this "gray zone" can be problematic using echocardiography and electrocardiography alone.

METHODS

Eight athletic men with genetically proven HCM and mild LVH (13.9 ± 1.1 mm) and eight elite male athletes matched for age, size and LVWT (13.4 ± 0.9 mm) underwent symptom limited metabolic exercise stress testing. Peak oxygen consumption (pVO₂), anaerobic threshold, oxygen pulse and respiratory exchange ratios were measured in both groups and compared with those observed in 12 elite and 12 recreational age- and size-matched athletes without LVH.

RESULTS

Elite athletes with LVH had significantly greater pVO₂ (66.2 ± 4.1 ml/kg/min vs. 34.3 ± 4.1 ml/kg/min; p < 0.0001), anaerobic threshold (61.6 ± 1.8% of the predicted maximum VO₂ vs. 41.4 ± 4.9% of the predicted maximum VO₂; p < 0.001) and oxygen pulse (27.1 ± 3.2 ml/beat vs. 14.3 ± 1.8 ml/beat; p < 0.0001) than individuals with HCM. A pVO₂ >50 ml/kg/min or >20% above the predicted maximum VO₂ differentiated athlete’s heart from HCM.

CONCLUSIONS

Metabolic exercise testing facilitates the differentiation between physiologic LVH and HCM in individuals in the "gray zone."

Abbreviations and Acronyms   AT = anaerobic threshold   A-V = systemic arteriovenous oxygen difference   BP = blood pressure   ECG = electrocardiogram   HCM = hypertrophic cardiomyopathy   HR = heart rate   LV = left ventricular   LVH = left ventricular hypertrophy   LVWT = left ventricular wall thickness   O2P = oxygen pulse   pVO2 = peak oxygen consumption   RER = respiratory exchange ratio   SV = stroke volume   VCO2 = carbon dioxide production   VO2 = oxygen consumption   VO2 max = maximal oxygen consumption

This article has been cited by other articles:

				S. Gupta, T. Baman, and S. M. Day Cardiovascular Health, Part 1: Preparticipation Cardiovascular Screening Sports Health: A Multidisciplinary Approach, November 1, 2009; 1(6): 500 - 507. [Abstract] [Full Text] [PDF]

				J. Rawlins, A. Bhan, and S. Sharma Left ventricular hypertrophy in athletes Eur J Echocardiogr, May 1, 2009; 10(3): 350 - 356. [Abstract] [Full Text] [PDF]

				D. Corrado, C. Basso, A. Pelliccia, and G. Thiene CHAPTER 32 Sports and Heart Disease ESC Textbook of Cardiovascular Medicine, January 1, 2009; 2(1): med-9780199566990-chapter - med-9780199566990-chapter. [Abstract] [Full Text] [PDF]

				R. Y Khamis and J. Mayet Echocardiographic assessment of left ventricular hypertrophy in elite athletes Heart, October 1, 2008; 94(10): 1254 - 1255. [Full Text] [PDF]

				S. Basavarajaiah, A. Boraita, G. Whyte, M. Wilson, L. Carby, A. Shah, and S. Sharma Ethnic differences in left ventricular remodeling in highly-trained athletes relevance to differentiating physiologic left ventricular hypertrophy from hypertrophic cardiomyopathy. J. Am. Coll. Cardiol., June 10, 2008; 51(23): 2256 - 2262. [Abstract] [Full Text] [PDF]

				S. Basavarajaiah, M. Wilson, G. Whyte, A. Shah, W. McKenna, and S. Sharma Prevalence of hypertrophic cardiomyopathy in highly trained athletes: relevance to pre-participation screening. J. Am. Coll. Cardiol., March 11, 2008; 51(10): 1033 - 1039. [Abstract] [Full Text] [PDF]

				S. Basavarajaiah, A. Shah, and S. Sharma Sudden cardiac death in young athletes Heart, March 1, 2007; 93(3): 287 - 289. [Abstract] [Full Text] [PDF]

				B. J. Maron and A. Pelliccia The Heart of Trained Athletes: Cardiac Remodeling and the Risks of Sports, Including Sudden Death Circulation, October 10, 2006; 114(15): 1633 - 1644. [Full Text] [PDF]

				S Basavarajaiah, M Wilson, S Junagde, G Jackson, G Whyte, S Sharma, and W O Roberts Physiological left ventricular hypertrophy or hypertrophic cardiomyopathy in an elite adolescent athlete: role of detraining in resolving the clinical dilemma * Commentary Br. J. Sports Med., August 1, 2006; 40(8): 727 - 729. [Abstract] [Full Text] [PDF]

				A Anastasakis, C Kotsiopoulou, A Rigopoulos, A Theopistou, N Protonotarios, D Panagiotakos, N Mammalis, and C Stefanadis Similarities in the profile of cardiopulmonary exercise testing between patients with hypertrophic cardiomyopathy and strength athletes Heart, November 1, 2005; 91(11): 1477 - 1478. [Full Text] [PDF]

				A. Pelliccia, R. Fagard, H. H. Bjornstad, A. Anastassakis, E. Arbustini, D. Assanelli, A. Biffi, M. Borjesson, F. Carre, D. Corrado, et al. Recommendations for competitive sports participation in athletes with cardiovascular disease: A consensus document from the Study Group of Sports Cardiology of the Working Group of Cardiac Rehabilitation and Exercise Physiology and the Working Group of Myocardial and Pericardial Diseases of the European Society of Cardiology Eur. Heart J., July 2, 2005; 26(14): 1422 - 1445. [Full Text] [PDF]

				D. L. King, L. El-Khoury Coffin, and M. S. Maurer Myocardial contraction fraction: a volumetric index of myocardial shortening by freehand three-dimensional echocardiography J. Am. Coll. Cardiol., July 17, 2002; 40(2): 325 - 329. [Abstract] [Full Text] [PDF]

				D J R Hildick-Smith and L M Shapiro Echocardiographic differentiation of pathological and physiological left ventricular hypertrophy Heart, June 1, 2001; 85(6): 615 - 619. [Full Text]